Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
Drug Patent Expirations and the “Patent Cliff”
Patents mean big business to big pharma
Generic drugs: Navigating the Patent Cliff: The Rise of Generic Drugs - FasterCapital
Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
Pharmaceuticals | Free Full-Text | Biosimilars: Company Strategies to Capture Value from the Biologics Market
TEVA drug pipeline, global patents
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
List - 54 Drug Patents Expiring in 2024 - GreyB
Patent expiry dates for biologicals: 2018 update - GaBI Journal
TEVA PHARMS USA drug pipeline, international patents
The biggest drug patent losses for 2013 - GaBI Journal
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Corcept Therapeutics: Far More Constructive With Korlym Resolve (NASDAQ:CORT) | Seeking Alpha
Teva generics revenue by region 2016-2023 | Statista
Patent expiry dates for biologicals: 2018 update - GaBI Journal
US Supreme Court rejects Teva challenge to $235 million GSK award in patent dispute | Reuters
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
List - 91 Drug Patents that are Expiring between 2020 to 2022 - GreyB
Several blockbuster patents to expire in 2023 - BioStock
High-Court-Sides-Teva-Patent
Generic Drugs in the Pipeline: 2017 Update
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceutical: Generic Market Access to Global Healthcare Industry | IntechOpen
Idea of the Week: Teva Pharmaceutical—The Top Leader in Generic Drugs | Bondsupermart
